Fitzky B U, Glossmann H, Utermann G, Moebius F F
Institut für Biochemische Pharmakologie, Universität Innsbruck, Austria.
Curr Opin Lipidol. 1999 Apr;10(2):123-31. doi: 10.1097/00041433-199904000-00006.
The Smith-Lemli-Opitz syndrome is a disorder of morphogenesis resulting from an enzymatic defect in the last step of cholesterol metabolism (reduction of 7-dehydrocholesterol). Analysis of the defective gene and identification of mutations therein have paved the way for the study of the molecular genetics of the disorder which is caused by numerous different mutations. Future efforts should identify a postulated intracellular signalling activity of sterol intermediates, isolate proteins that govern the sterol traffic between intracellular compartments, structurally characterize the enzyme delta 7-sterol reductase defective in the Smith-Lemli-Opitz syndrome and investigate the pathomechanism of sterol depletion-induced dysmorphogenesis.
史密斯-利姆利-奥皮茨综合征是一种形态发生障碍,由胆固醇代谢最后一步(7-脱氢胆固醇还原)中的酶缺陷引起。对缺陷基因的分析及其突变的鉴定为该疾病分子遗传学的研究铺平了道路,该疾病由众多不同突变引起。未来的研究应确定固醇中间体假定的细胞内信号传导活性,分离控制细胞内区室之间固醇运输的蛋白质,对史密斯-利姆利-奥皮茨综合征中缺陷的δ7-固醇还原酶进行结构表征,并研究固醇耗竭诱导的畸形发生的发病机制。